Matches 251 - 300 out of 530 < 1 2 3 4 5 6 7 8 9 10 11 >
Match Document Document Title
6270799 Medicament formulation with a controlled release of an active agent  
The invention relates to drug formulations which comprise 1-cyclopropyl-7-([S,S]-2,8-diazabicyclo[4.3. 0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quino-lon ecarboxylic acid and/or...
6267986 Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine  
This invention relates to a process for the preparation of a controlled release pharmaceutical composition comprising two discrete zones wherein the first discrete zone comprises therapeutically...
6264985 Laminated tablet with pointed core  
A dry-coated tablet for controlled release of active substance, having an erodible core tablet (1) containing at least one active substance, and a substantially erosion-resistant shell consisting...
6264974 Buccal and sublingual administration of physostigmine  
Physostigmine, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5ol methylcarbamate, administered buccally or sublingually in non-sustained release dosage form provides extremely...
6258381 Tablet and process for making the same  
A tablet and process for making the same is provided. The tablet is made from a granular agglomerate comprising a mixture of at least one active ingredient and a binder. The granular agglomerate is...
6254866 Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract  
A method for treatment of bacterial infections of the digestive tract is disclosed which comprises administering a lytic enzyme specific for the infecting bacteria. The lytic enzyme is preferably...
6251430 Water insoluble polymer based sustained release formulation  
Sustained release drug formulations contain the pharmaceutical itself and a three component release rate controlling matrix composition. The three components of the matrix composition are (1) water...
6248355 Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation  
A composition, particularly adapted for oral administration, containing omeprazole, and a method for preparing the composition, are disclosed. The composition, being exempt of alkaline-reacting...
6248760 Tablet giving rapid release of nicotine for transmucosal administration  
A tablet for the transmucosal administration of nicotine. The nicotine is in one or more layers upon a non-nicotine containing matrix. The nicotine layers rapidly dissolve in the mouth. The...
6248359 Multi-tablet oxybutynin system for treating incontinence  
The present invention provides a simple multi-tablet system for the treatment of urinary incontinence with oxybutynin. Particular embodiments of the invention provide a first tablet that releases...
6248307 Compositions and treatment for alleviation of symptoms associated with menopause  
A composition having at least one herbal compound and at least one homeopathic drug is useful for treating symptoms associated with menopause. Methods of preparing the composition and methods of...
6238698 Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium  
An oral preparation, comprising at least one pharmaceutical active compound in a matrix which is swellable in aqueous medium, which is released from the matrix into the aqueous medium in a delayed...
6235311 Pharmaceutical composition containing a combination of a statin and aspirin and method  
A pharmaceutical composition is provided which is useful for cholesterol lowering and reducing the risk of a myocardial infarction, which includes a statin, such as pravastatin, lovastatin,...
6224911 Process for the preparation of enteric coated pharmaceutical dosage forms  
This invention is directed to a process for the preparation of enteric coated pharmaceutical dosage forms. This invention is further directed to the aqueous enteric coating dispersions suitable for...
6221395 Controlled release pharmaceutical tablets containing an active principle of low water solubility  
It is described a new method for the preparation of pharmaceutical tablets carrying poorly soluble in water principle; this method allows to obtain tablets with fast and/or slow release of the...
6221396 Oral cisapride dosage forms with an extended duration  
The present invention provides sustained release oral solid dosage forms of cisapride by using a multi-particulate system, which are bioavailable and can provide efficient blood level of cisapride...
6217903 Sustained release polymer blend for pharmaceutical applications  
A pharmaceutical composition has a blend of at least first and second components and a medicament in a sufficient amount to be therapeutic where the first component is ethylcellulose (EC) and the...
6214379 Maximizing effectiveness of substances used to improve health and well being  
The present disclosure relates to novel dosage forms, drug delivery regimens, methods and pharmaceutical compositions which optimize the therapeutic effects of active therapeutic substances through...
6200602 Composition for enhanced uptake of polar drugs from the colon  
The invention provides a drug delivery composition for colonic delivery comprising a polar drug, an absorption promoter which (a) comprises a mixture of a fatty acid having 6 to 16 carbon atoms or...
6197341 Formulations of balsalazide and its derivatives  
The invention provides a unit formulation which comprises a 2-hydroxy-5-phenylazobenzoic acid derivative which is particularly sodium balsalazide dihydrate which formulation has a density of at...
6197314 Impeding the extraction of active ingredients out of tablets  
Solid oral administration forms from which the active ingredients can be isolated only with difficulty are described and comprise, besides conventional ingredients, as addition a mixture of...
6197336 Fast dissolving compositions having analgesic activity  
An analgesic composition useful in the preparation of fast dissolving tablets is provided, where the composition is the result of combining ibuprofen, arginine, linear PVP and an alkaline...
6187341 Trovafloxacin mesylate tablet  
Compositions, especially in the form of tablets containing the polymorph II form of trovafloxacin mesylate, a lubricant, and microcrystalline cellulose (MC) as the diluent. Such compositions...
6187337 Rapidly dissolving dosage form  
A particulate support matrix, and a dosage form made therefrom, and processes for making such support matrices and dosage forms, which disintegrate or dissolve in a matter of just a few seconds...
6187340 Stabilized pharmaceutical preparation  
A stabilized pharmaceutical preparation which is coated with a coating agent comprising an agent for the protection from light, said agent being capable of producing free radicals when exposed to...
6183778 Pharmaceutical tablet capable of liberating one or more drugs at different release rates  
Pharmaceutical tablet consisting of a first layer containing one or more drugs with immediate or controlled release formulation, a second layer containing one or more drugs, either equal to or...
6183780 Oral delayed immediate release formulation and method for preparing the same  
The invention relates to an Oral Delayed Immediate Release formulation comprising a compressed core containing one or more active substances surrounded with a coating, wherein release of active...
6177101 Delavirdine high strength tablet formulation  
Disclosed is a non-sustained release pharmaceutical tablet composition which comprises a rapidly precipitating drug in an amount from about 5 to about 60% and at least one member selected from the...
6177102 Once daily analgesic tablet  
An analgesic controlled release dosage form containing: (a) 40-80 weight percent of an analgesic; (b) 10-30 weight percent of a pharmaceutically acceptable filler; and (c) 10-30 weight percent of a...
6174542 Dietary supplements and food products for treating symptoms of PMS  
A chocolate containing dietary, vitamin, mineral and herbal supplement, and food products containing the same, for treating, preventing, alleviating or managing symptoms associated with...
6172107 Entric-coated pharmaceutical compositions  
This invention provides a pharmaceutical composition comprising a mycophenolate salt, the composition being adapted to release mycophenolate in the upper part of the intestinal tract.
6159499 Composition containing an acid-labile benzimidazole and process for its preparation  
The present invention relates to a composition, particularly adapted to oral administration, substantially free of alkaline-reacting compounds. The composition comprises (a) a core containing an...
6156342 Controlled release oral dosage form  
A controlled release dosage form for an analgesic that does not contain an expanding polymer and comprising a core containing the analgesic, preferably tramadol or it pharmaceutically acceptable...
6156343 Controlled release preparation  
A controlled release preparation consisting of a tablet containing (a) a mixture of a drug and a water-soluble polymer, or a solid dispersion thereof, (b) polyvinylalcohol and (c) one or more salts...
6156340 Orally administrable time release drug containing products  
A time release orally administrable drug containing product comprising a core, a drug layer attached to the core, and first and second coating layers is disclosed. The first coating layer is...
6156341 Low-dosed steroid tablets that contain gallic acid ester as an antioxidant, process for production, and use  
Pharmaceutical agents that contain a gallic acid ester as an antioxidant in combination with a steroidal active ingredient, their production and their use.
6149940 Tablet with controlled release of alfuzosine chlorhydrate  
Pharmaceutical tablet which consists of: a) a first layer having the property of swelling considerably and quickly on contact with aqueous biological fluids, the first layer being produced by...
6149939 Healthful dissolvable oral tablets, and mini-bars  
Dissolvable oral tablets and mini-bars which contain healthful ingredients. The products contain a multitude of discrete, extruded sections containing different healthful ingredients. A wide...
6146661 Chewable tablet  
Chewable tablets prepared by incorporating a sugar alcohol with a dissolution endotherm of 20 calories or more per gram of a gastrointestinally active ingredient such as a mucous membrane repairing...
6143325 Nefazodone dosage form  
Extended-release nefazodone compositions containing nefazodone hydrochloride, ionic and non-ionic gelling polymers, an insoluble hydrophilic agent, and optional pharmaceutically acceptable...
6132769 Pharmaceutical matrix pellets, tablets and composition for the preparation thereof  
The present invention relates to pharmaceutical matrix pellet formulations providing an adequate drug release profile. The matrix of said pellets is formed from: (a) a hydrophilic compound...
6126970 Cisapride sustained release  
6124355 Oxybutynin therapy  
A composition comprising oxybutynin, a dosage form comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
6120802 Method of producing multi-layer medicaments in solid form for oral or rectal administration  
The present invention relates to a process for producing multilayer, solid drug forms for oral or rectal administration, which comprises coextrusion of at least two compositions which in each case...
6117450 Method of making a perorally administered solid drug with controlled effective ingredient delivery  
The method of making a solid drug with controlled effective ingredient delivery for oral administration includes selecting a predetermined number of at least three of four compressed compositions...
6113945 Multi-colored medicament  
The medicament of the present invention and its process of manufacturing employs a caplet or tablet core with a clear or single color uniform covering which can be applied either through an...
6110500 Coated tablet with long term parabolic and zero-order release kinetics  
A tablet for the controlled release of an active pharmaceutical ingredient. The tablet comprises a core having a donut-like configuration with a cylindrical hole extending through the center of the...
6106863 Sustained-release metal valproate tablets  
The present invention provides a sustained-release metal valproate tablet which is comparatively compact and is not influenced by a meal, the sustained-release metal valproate comprising a core...
6103264 Process for preparing a controlled release composition  
A process for preparing a controlled release composition with a controlled release matrix and containing a pharmaceutically active ingredient, which comprises granulating the active ingredient with...
6099862 Oral dosage form for the controlled release of a biguanide and sulfonylurea  
A controlled release pharmaceutical tablet containing antihyperglycemic drug and a hypoglycemic drug that does not contain an expanding or gelling polymer layer and comprising a core containing the...
Matches 251 - 300 out of 530 < 1 2 3 4 5 6 7 8 9 10 11 >